openPR Logo
Press release

Companion Diagnostics Market Growth, Size, Share and Forecast 2020-2026

06-30-2020 01:06 PM CET | Health & Medicine

Press release from: Orion Market Research

Companion Diagnostics Market Growth, Size, Share and Forecast

The global companion diagnostics market is projected to exhibit a significant growth, at a CAGR of around 12.8%, during the forecast period. Companion diagnostics market is expected to gain a huge growth during the forecast period, backed by the number of partnerships and collaborations announced by market players in the past one year. Several key market players, such as Thermo Fisher Scientific Inc., Promega Corp., QIAGEN NV, Myriad Genetics, Inc., AstraZeneca PLC, and Merck Co. & Inc. announced some partnerships and collaborations, to expand their foothold in the companion diagnostics market across the globe. Some of the recent collaborations and partnerships are listed in the following points-

A full report of Global Companion Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/companion-diagnostics-market

• In March 2020, Thermo Fisher Scientific Inc. entered a partnership with Janssen Biotech, Inc. for the co-development of CDx in oncology. Through the partnership, the companies will work with the Janssen’s scientists to validate the use of multiple biomarkers that can be used with Thermo Fisher’s Oncomine Dx target test. This test will be available for the identification of variant-positive patients non-small cell lung cancer (NSCLC).
• In January 2020, Guardant Health, Inc. collaborated with Amgen for the development and support the commercialization of a blood based CDx test for Amgen’s AMG 510. Through collaboration, the company will pursue US FDA pre-market approval, European CE mark, and Japan Pharmaceutical and Medical Device Agency approval for Guardant360 CDx as a companion diagnostic test for AMG 510 for patients suffering from metastatic NSCLC with the KRAS G12C mutation.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/companion-diagnostics-market

• In November 2019, Promega Corp. collaborated with Merck, to develop the company’s microsatellite instability (MSI) technology, which is an on-label solid tumor CDx that can be used with Merck’s anti-PD-1 therapy, KEYTRUDA.
• In October 2019, QIAGEN NV signed a partnership agreement with Illumina, Inc. for the development of NGS-based IVD kits, including companion diagnostics for the health management of patients. Though agreement, the company has gained a non-exclusive right for the development and commercialization of IVD kits to be used with Illumina’s MiSeq Dx and NextSeq 550Dx Systems. Along with this, the agreement also includes rights related to the expansion of partnership with Illumina Dx systems in the future.
• In April 2019, Myriad Genetics, Inc. collaborated with AstraZeneca and Merck, to expand its companion diagnostics portfolio.
Through the collaboration, the companies will use BRACAnalysis CDx for the identification of germline BRCA mutations in men suffering from metastatic castrate-resistant prostate cancer and have been enrolled in the Phase III PROfound (NCT02987543) study. This will lead to significant advancement in Myriad’s precision treatment for patients dealing with ovarian or breast cancer.

Global Companion diagnostics Market-Segmentation

By Technology

• Polymerase Chain Reaction (PCR)
• In Situ Hybridization (ISH)
• Immunohistochemistry (IHC)
• Next-Generation Sequencing (NGS)
• Others (Gene Sequencing)

By Indication

• Breast Cancer
• Lung Cancer
• Melanoma
• Neurological Diseases
• Others (Gastric Cancer)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/companion-diagnostics-market

Global Companion diagnostics Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Abbott Laboratories
• Abnova Corp.
• Agilent Technologies, Inc.
• Almac Group
• Amgen Inc.
• AstraZeneca PLC
• Biocartis NV
• bioMérieux SA
• F. Hoffmann-La Roche Ltd.
• Guardant Health, Inc.
• Illumina, Inc.
• Leica Biosystems
• Merck & Co., Inc.
• Myriad Genetics, Inc.
• Promega Corp.
• Protagen AG
• QIAGEN NV
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market Growth, Size, Share and Forecast 2020-2026 here

News-ID: 2082146 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Market
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test